Mineral homeostasis in children with acute lymphoblastic leukemia before and after chemotherapy

C Y Jamal1, M A Karim, M H Rahman

  • 1Department of Pediatric Hematology and Oncology, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, Bangladesh.

Insights

This study found significant changes in serum phosphate levels in children undergoing acute lymphoblastic leukemia (ALL) treatment. Mineral levels, including calcium and phosphate, were monitored before and after induction chemotherapy.

Area of Science:

  • Pediatric Oncology
  • Biochemistry
  • Hematology

Background:

  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
  • Chemotherapy for ALL can lead to significant metabolic and mineral disturbances.
  • Monitoring mineral changes is crucial for managing treatment side effects in pediatric ALL patients.

Purpose of the Study:

  • To evaluate mineral level alterations in children with ALL.
  • To compare pre-induction and post-induction chemotherapy mineral profiles.
  • To identify significant changes in serum calcium, phosphate, and alkaline phosphatase.

Main Methods:

  • Prospective study design.
  • Inclusion of 32 children (aged 1-14 years) diagnosed with ALL.
  • Measurement of serum calcium, phosphate, alkaline phosphatase, albumin, creatinine, and urinary calcium and creatinine.

Main Results:

  • Serum phosphate levels showed a statistically significant decrease post-induction chemotherapy.
  • Mean serum calcium levels slightly decreased but not significantly.
  • Serum alkaline phosphatase levels increased post-induction, but the change was not statistically significant.

Conclusions:

  • Induction chemotherapy for ALL significantly impacts serum phosphate levels in children.
  • Close monitoring of mineral balance is essential during pediatric ALL treatment.
  • Further research may explore interventions to mitigate chemotherapy-induced mineral imbalances.